静脉留置针对结直肠癌化疗病人静脉化疗疗程疼痛影响  

INTRAVENOUS INDWELLING THERAPY INTERVENTION AFFECTS COLORECTAL CANCER PATIENTS'INTRAVENOUS CHEMOTHERAPY PAIN

作　　者：王诗淇 王学梅 张玉超 赵灵燕 侯明星[3] WANG Shi-qi;WANG Xue-mei;ZHANG Yu-chao(Inner Mongolia Medical University＇Hohhot 010010 China）D)

机构地区：[1]内蒙古医科大学公共卫生学院,内蒙古呼和浩特010110 [2]乌海市人民医院 [3]内蒙古医科大学附属医院

出　　处：《内蒙古医科大学学报》2018年第4期358-361,共4页Journal of Inner Mongolia Medical University

基　　金：内蒙古自治区高等学校科学研究项目(NJZY14149)

摘　　要：目的:探讨静脉留置针对结直肠腺癌化疗病人静脉化疗疗程中疼痛影响的效果评价。方法:将乌海市人民医院肿瘤科收治的60名腺癌静脉化疗病人作为试验组(水胶体+喜辽妥),按性别、年龄、分化程度为匹配条件,从同期进行化疗的腺癌病人中随机抽取60例为对照组单独使用喜辽妥。观察不同化疗疗程两组病人上肢疼痛程度和静脉炎的发生率。结果:第一、二个疗程两组病人的疼痛程度有统计学意义(P<0.05)。第三个疗程两组病人的疼痛程度差异无统计学意义(P>0.05);两组静脉炎发生率比较差异有统计学意义(P<0.05)。结论:早期使用水胶体敷料和喜辽妥可减轻结直肠癌化疗病人的上肢疼痛程度,降低静脉炎的发生率,提高病人的舒适度。Objective ： To explore the intravenous indwelling therapy intervention prevent colorectal adenocarcinoma patients ’intravenous chemotherapy pain during 3 chemotherapy course.Methods：60 patients with adenocarcinoma of intravenous chemotherapy in Wuhai City People’s Hospital oncologyreated as the test group （ hydrocolloid ＋ Hirudoid ） , by gender, age, the degree of differentiation asmatching conditions, 60 adenocarcinoma patients undergoing chemotherapy from the same period was randomly selected as control group（Hirudoid used alone） . T＇o observe the degree of incidence of chemo-herapy treatment in patients with upper extremity pain and phlebitis groups. I^esults ： The pain level ofhe first and the second treatment shows significant differences（P〈0.05） .And there was no significant differences between two groups on the third course（P〉0.05） .Phlebitis proportion difference was statis-tically significant between two groups （P〈0.05 ）. Conclusion; Combination using of hydrocolloid and Hirudoid on colorectal patients at early chemotherapy stage could not only reduce pain level decrease the incidence of phlebitis,improve patients ’comfort.

关 键 词：水胶体 静脉炎 疼痛 介入 

分 类 号：R735.35[医药卫生—肿瘤]